|
|
|
|
|
Teisinis statusas
Patentas galioja
| (51) | INT.CL. | A61K 48/00 | (2006.01) |
| C12N 15/861 | (2006.01) |
| (11) | Patento numeris | 3821912 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 20199208.8 |
| Europos patento paraiškos padavimo data | 2015-07-17 | |
| (97) | Europos patento paraiškos paskelbimo data | 2021-05-19 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-06-12 |
| (46) | Apibrėžties vertimo paskelbimo data | 2024-09-25 |
| (30) | Numeris | Data | Šalis |
| 201462028638 P | 2014-07-24 | US |
| (72) |
SANDBERG, Michael A , US
PAWLYK, Basil , US
LI, Tiansen , US
SHU, Xinhua , GB
WRIGHT, Alan Finlay , GB
ALI, Robin , US
|
| (73) |
Massachusetts Eye & Ear Infirmary ,
243 Charles Street, Boston, MA 02114,
US
UCL Business Ltd , University College London Gower Street, London WC1E 6BT, GB The Government of the United States of America as represented by the Secretary, Department of Health and Human Services , The Office of Technology Transfer National Institutes of Health 6011 Executive Boulevard Suite 325, MSC 7660, Bethesda, MD 20892-7660, US |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | RPGR genų terapija pigmentiniam retinitui gydyti |
| RPGR GENE THERAPY FOR RETINITIS PIGMENTOSA |
| Mokėjimo data | Galiojimo metai | Suma | |
| 2025-07-01 | 11 | 289.00 EUR |
| 2026-07-17 |